Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Sempra stock logo
SRE
Sempra
$72.92
+0.1%
$70.65
$63.75
$78.70
$46.10B0.73.04 million shs3.45 million shs
TNR Gold Corp. stock logo
TNR
TNR Gold
C$0.06
+9.1%
C$0.06
C$0.05
C$0.08
C$11.09M0.7173,599 shs313,504 shs
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$177.07
$177.00
$103.67
$177.38
$16.26B1.06746,779 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Sempra stock logo
SRE
Sempra
+0.05%+2.24%+2.75%+2.21%-4.44%
TNR Gold Corp. stock logo
TNR
TNR Gold
+9.09%0.00%+20.00%+9.09%-7.69%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Sempra stock logo
SRE
Sempra
4.7416 of 5 stars
2.55.04.22.22.72.51.9
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
1.3219 of 5 stars
0.00.00.04.40.01.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Sempra stock logo
SRE
Sempra
2.90
Moderate Buy$82.1412.64% Upside
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Latest PFP, TNR, CUL, VAR, and SRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2024
Sempra stock logo
SRE
Sempra
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$74.00 ➝ $75.00
3/14/2024
Sempra stock logo
SRE
Sempra
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$77.00 ➝ $79.00
3/6/2024
Sempra stock logo
SRE
Sempra
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$82.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Sempra stock logo
SRE
Sempra
$16.72B2.76$8.26 per share8.83$52.03 per share1.40
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AC$0.00 per share50.00C$0.01 per shareN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$3.17B5.13$5.07 per share34.94$22.92 per share7.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Sempra stock logo
SRE
Sempra
$3.08B$4.7915.2214.162.5218.26%9.45%3.50%5/7/2024 (Confirmed)
TNR Gold Corp. stock logo
TNR
TNR Gold
C$8.19MC$0.041.50N/AN/AN/A-130.55%N/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$269.20M$3.9160.4330.11N/A8.50%18.45%8.08%N/A

Latest PFP, TNR, CUL, VAR, and SRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Sempra stock logo
SRE
Sempra
$1.50N/A-$1.50N/AN/AN/A  
2/27/202412/31/2023
Sempra stock logo
SRE
Sempra
$1.11$1.13+$0.02$1.10$4.01 billion$3.49 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Sempra stock logo
SRE
Sempra
$2.483.40%+4.43%51.77%21 Years
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/A

Latest PFP, TNR, CUL, VAR, and SRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
Sempra stock logo
SRE
Sempra
quarterly$0.623.5%3/20/20243/21/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Sempra stock logo
SRE
Sempra
0.85
0.54
0.49
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A
29.89
0.18
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/A
1.40
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Sempra stock logo
SRE
Sempra
89.65%
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
86.96%

Insider Ownership

CompanyInsider Ownership
Sempra stock logo
SRE
Sempra
0.24%
TNR Gold Corp. stock logo
TNR
TNR Gold
15.65%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Sempra stock logo
SRE
Sempra
16,835632.15 million630.63 millionOptionable
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A184.87 millionN/ANot Optionable
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
10,00091.84 millionN/AOptionable

PFP, TNR, CUL, VAR, and SRE Headlines

SourceHeadline
Gamma Knife Market Expected to See Impressive CAGR of 5.2% | Market.usGamma Knife Market Expected to See Impressive CAGR of 5.2% | Market.us
pharmiweb.com - May 3 at 12:11 PM
First cancer hospital in PH: ‘Quality meets affordability’First cancer hospital in PH: ‘Quality meets affordability’
msn.com - May 2 at 3:58 PM
Magnus Medical launches Saint neuromod system for major depressive disorder treatmentMagnus Medical launches Saint neuromod system for major depressive disorder treatment
massdevice.com - May 1 at 1:42 PM
Golden Shield Award presented to Ryan Varian with the City of Belpre EMSGolden Shield Award presented to Ryan Varian with the City of Belpre EMS
msn.com - April 30 at 10:42 PM
Spectrum and Hermes Medical Solutions to offer vendor-neutral softwareSpectrum and Hermes Medical Solutions to offer vendor-neutral software
msn.com - April 29 at 4:34 PM
Titan Medical gives progress report about Conavi mergerTitan Medical gives progress report about Conavi merger
therobotreport.com - April 27 at 10:16 AM
Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon TechnologyVarian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon Technology
prnewswire.co.uk - April 25 at 5:58 PM
The effect of using a large language model to respond to patient messagesThe effect of using a large language model to respond to patient messages
thelancet.com - April 24 at 10:26 PM
CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024
prnewswire.co.uk - April 24 at 12:26 PM
Healthway Cancer Care Hospital offers world-class cancer care at affordable pricesHealthway Cancer Care Hospital offers world-class cancer care at affordable prices
businessmirror.com.ph - April 24 at 12:26 PM
Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”
bizjournals.com - April 22 at 1:59 PM
DelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightDelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finanznachrichten.de - April 18 at 6:35 PM
This device treats overactive bladder without drugs or surgeryThis device treats overactive bladder without drugs or surgery
medicaldesignandoutsourcing.com - April 18 at 6:35 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightGlobal Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finance.yahoo.com - April 18 at 6:35 PM
Raigmore Hospital in Scotland selects RayCareRaigmore Hospital in Scotland selects RayCare
finance.yahoo.com - April 17 at 3:14 PM
PH’s 1st dedicated cancer hospital rises in Taguig CityPH’s 1st dedicated cancer hospital rises in Taguig City
msn.com - April 15 at 10:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™
finance.yahoo.com - April 15 at 5:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarketsRobotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets
finanznachrichten.de - April 15 at 12:34 PM
Ayala cancer hospital ready to serve 10,000 patients this yearAyala cancer hospital ready to serve 10,000 patients this year
msn.com - April 11 at 2:56 PM
Global Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMIGlobal Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMI
fmiblog.com - April 8 at 6:11 PM
Next-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancerNext-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancer
eurekalert.org - April 8 at 1:10 PM
The Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggestsThe Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests
eurekalert.org - April 5 at 1:10 AM
Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032
fmiblog.com - April 4 at 1:43 AM
New method allows miniature robots and surgical instruments to achieve precise localization inside the bodyNew method allows miniature robots and surgical instruments to achieve precise localization inside the body
msn.com - April 2 at 3:39 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Sempra logo

Sempra

NYSE:SRE
Sempra operates as an energy infrastructure company in the United States and internationally. It operates through three segments: Sempra California, Sempra Texas Utilities, and Sempra Infrastructure. The Sempra California segment provides electric services; and natural gas services to San Diego County. As of December 31, 2023, it offered electric services to approximately 3.6 million population and natural gas services to approximately 3.3 million population that covers 4,100 square miles. This segment owns and operates a natural gas distribution, transmission, and storage system that supplies natural gas. As of December 31, 2023, it serves a population of 21 million covering an area of 24,000 square miles. The Sempra Texas Utilities segment engages in the regulated electricity transmission and distribution. As of December 31, 2023, its transmission system included 18,298 circuit miles of transmission lines; 1,257 transmission and distribution substations; interconnection to 173 third-party generation facilities totaling 54,277 MW; and distribution system included approximately 4.0 million points of delivery and consisted of 125,116 miles of overhead and underground lines. The Sempra Infrastructure segment develops, builds, operates, and invests in energy infrastructure to help enable the energy transition in North American markets and worldwide. The company was formerly known as Sempra Energy and changed its name to Sempra in May 2023. Sempra was founded in 1998 and is based in San Diego, California.
TNR Gold logo

TNR Gold

CVE:TNR
TNR Gold Corp. engages in the acquisition, exploration, and evaluation of mineral properties. The company explores for gold, copper, silver, and lithium deposits. It holds a 90% interest in the Shotgun gold project located in the southwestern Alaska. The company also holds royalty interests in the Los Azules Copper and Mariana Lithium projects located in Argentina. TNR Gold Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
Varian Medical Systems logo

Varian Medical Systems

NYSE:VAR
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.